• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性乳腺癌/卵巢癌综合征:妇产科医生指南。

Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

机构信息

Department of Gynecology and Obstetrics, Emory University School of Medicine, 49 Jesse Hill Jr Drive, Atlanta, GA 30303, USA.

出版信息

Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30.

DOI:10.1016/j.ogc.2013.05.009
PMID:24021253
Abstract

An understanding of the diagnosis and clinical management of hereditary breast and ovarian cancer syndrome (HBOC) is essential for obstetricians/gynecologists. This article provides practical information regarding collecting a family history, cancer risk assessment and genetic testing, BRCA-associated cancer prognosis and treatment, screening recommendations, and prevention strategies. Through appropriate cancer risk assessment, women with BRCA1/2 mutations can be identified, and screening and prevention strategies can be used before a diagnosis of cancer occurs. Women's health providers with a strong working knowledge of HBOC are able to improve the quality of care for women and families impacted by BRCA1/2 mutations.

摘要

了解遗传性乳腺癌和卵巢癌综合征 (HBOC) 的诊断和临床管理对于妇产科医生来说至关重要。本文提供了有关收集家族史、癌症风险评估和基因检测、BRCA 相关癌症预后和治疗、筛查建议和预防策略的实用信息。通过适当的癌症风险评估,可以识别出携带 BRCA1/2 突变的女性,并在癌症诊断前使用筛查和预防策略。对 HBOC 有深入了解的女性健康提供者能够提高受 BRCA1/2 突变影响的女性和家庭的护理质量。

相似文献

1
Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.遗传性乳腺癌/卵巢癌综合征:妇产科医生指南。
Obstet Gynecol Clin North Am. 2013 Sep;40(3):475-512. doi: 10.1016/j.ogc.2013.05.009. Epub 2013 Jul 30.
2
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.BRCA1/2 基因突变在散发性乳腺癌/卵巢癌患者中的流行情况,以及在诊断为晚发性乳腺癌和卵巢癌的患者中发现一种新的从头 BRCA1 突变:对遗传检测的影响。
Breast Cancer Res Treat. 2012 Feb;132(1):87-95. doi: 10.1007/s10549-011-1544-9. Epub 2011 May 7.
3
Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.遗传性乳腺癌和卵巢癌:妇产科医生的最新入门读物。
Obstet Gynecol Clin North Am. 2022 Mar;49(1):117-147. doi: 10.1016/j.ogc.2021.11.005.
4
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.斯洛伐克遗传性乳腺癌/卵巢癌家系的综合遗传特征分析。
Breast Cancer Res Treat. 2011 Feb;126(1):119-30. doi: 10.1007/s10549-010-1325-x. Epub 2011 Jan 4.
5
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.多基因panel 检测在遗传性乳腺癌和卵巢癌风险评估中的临床可操作性。
JAMA Oncol. 2015 Oct;1(7):943-51. doi: 10.1001/jamaoncol.2015.2690.
6
Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.BRCA1 突变携带者行预防性输卵管卵巢切除术的经验及遗传性乳腺癌卵巢癌综合征预防性手术体系在日本的建立:我们未来的挑战。
Jpn J Clin Oncol. 2013 May;43(5):515-9. doi: 10.1093/jjco/hyt036. Epub 2013 Mar 13.
7
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.在阿什肯纳兹族乳腺癌和卵巢癌家族中未发现基因组 BRCA1 和 BRCA2 重排。
Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11.
8
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.遗传性乳腺癌和卵巢癌(HBOC):BRCA1 和 BRCA2、林奇综合征、考登综合征和李-佛美尼综合征的临床特征和咨询。
Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003.
9
[Molecular Diagnosis and Treatment of HBOC Syndrome].[遗传性乳腺癌卵巢癌综合征的分子诊断与治疗]
Gan To Kagaku Ryoho. 2017 Feb;44(2):102-106.
10
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.与BRCA1和BRCA2基因突变相关的遗传性乳腺癌卵巢癌综合征家族中女性接受预防性卵巢切除术后的腹腔内癌转移
Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039.

引用本文的文献

1
Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours.基层医疗中乳腺癌风险评估与一级预防建议:对医疗服务提供者态度和常规行为的系统评价
Cancers (Basel). 2021 Aug 18;13(16):4150. doi: 10.3390/cancers13164150.
2
Peritoneal cancer after bilateral mastectomy, hysterectomy, and bilateral salpingo-oophorectomy with a poor prognosis: A case report and review of the literature.双侧乳房切除术、子宫切除术及双侧输卵管卵巢切除术后发生的腹膜癌,预后不良:一例病例报告及文献综述
World J Clin Cases. 2019 Nov 26;7(22):3872-3880. doi: 10.12998/wjcc.v7.i22.3872.
3
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.